Regulatory context
Regulatory context; not efficacy evidence
No matched controlled clinical study of this exact preparation was verified in this source audit.
Reported findings. Background context only. Matched evidence for the exact marketed formulation is not established by this reference.
Nonresponse. Nonresponse frequency not established in this excerpt.
Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.
Limits. Related-compound evidence is contextual only. Commercial names, modifications and routes do not establish clinical equivalence.
Preparation: Source preparation; commercial equivalence unverified. Route: Unknown in reviewed excerpt; do not infer.
Read original source ↗Editorial review 2026-10-09. Clinician review pending.
Lab or animal research
Stem cell recovering effect of copper-free GHK in skin.
Foreskin-derived cultured keratinocytes/fibroblasts and reconstructed skin-equivalent models.
Reported findings. Increased proliferation and integrin, p63 and PCNA-associated markers were reported.
Nonresponse. Epidermal thickness did not significantly increase.
Harms. A 24-hour cell-cytotoxicity assay reportedly found no cytotoxicity, data not shown; human tolerability was not established.
Limits. Authors explicitly leave trace copper binding in medium unresolved; a copper-independent mechanism is not proved. Human-derived cells and skin equivalents are preclinical models, not treated-patient outcomes.
Preparation: Beadtech-supplied Gly-His-Lys without added copper; trace copper in culture medium could bind GHK. Route: Culture-medium exposure; not a patient treatment route.
Read original source ↗Editorial review 2026-10-10. Clinician review pending.